Skip to content
Search

Latest Stories

India, UK to study efficacy of Ashwagandha on Covid patients

India, UK to study efficacy of Ashwagandha on Covid patients

INDIA's Ayush ministry has collaborated with the UK's London School of Hygiene and Tropical Medicine (LSHTM) to conduct clinical trials of Ashwagandha to study the efficacy of the herb on Covid patients.

The All India Institute of Ayurveda (AIIA), under the Ayush ministry, and LSHTM recently signed a memorandum of understanding to conduct trials on 2,000 people in three UK cities-Leicester, Birmingham, and London (Southall and Wembley), a statement said.


Ashwagandha (Withania somnifera), commonly known as 'Indian winter cherry', is a traditional herb that boosts energy, reduces stress, and makes the immune system stronger.

The herb is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile, the statement added.

This is the first time the ministry is collaborating with a foreign institution to investigate its efficacy on Covid-19 patients.

AIIA director Dr Tanuja Manoj Nesari, who is also a co-investigator in the project has said that the participants have been randomly selected.

Dr Rajgopalan, coordinator – International Projects is also participating in the project. Dr Sanjay Kinra of LSHTM is the principal investigator of the study.

"For three months, one group of 1,000 participants will be administered Ashwagandha (AG) tablets while the second group of 1,000 participants will be assigned a placebo, which is indistinguishable from AG in looks and taste. Both patients and the doctors will be unaware of the group's treatment in a double-blind trial," Dr Nesari said.

"The participants will have to take the 500 mg tablets twice a day. A monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use, and adverse events will be carried out."

She added that the study has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and certified by WHO-GMP. It is being conducted and monitored as per the internationally recognized GCP (Good Clinical Practices) guidelines.

Recently, a number of randomized placebo-controlled trials of Ashwagandha in humans in India have demonstrated its efficacy in reducing anxiety and stress, improving muscle strength, and reducing symptoms of fatigue in patients treated for chronic conditions.

It has also been indicated for treating non-restorative sleep, a hallmark of chronic fatigue, for which the trials are currently ongoing, the statement added.

Many studies suggested Ashwagandha as a potential therapeutic candidate for alleviating the long-term symptoms of Covid-19, Dr Nesari said.

More For You

modi-bjp-reuters

BJP supporters celebrate in New Delhi. (Photo: Reuters)

Modi's BJP wins Delhi assembly election after 27 years

INDIAN prime minister Narendra Modi said on Saturday that "development had won" as his Bharatiya Janata Party (BJP) secured victory in Delhi’s local elections, ending a 27-year gap since it last controlled the capital’s legislature.

"Development has won, good governance has won," Modi said after Delhi’s former chief minister, a key opposition leader, conceded defeat.

Keep ReadingShow less
Uganda-high-commission-event

The event also focused on Uganda’s role in cultural diplomacy and sustainable development.

Uganda high commission hosts heritage event in London

THE UGANDA high commission in London hosted an event highlighting Uganda’s cultural heritage and investment opportunities at the International Maritime Organization (IMO) Building. The event featured a performance by the Watoto Children’s Choir.

Uganda’s high commissioner to the UK, Nimisha J Madhvani, addressed the gathering, welcoming guests and speaking about the country’s cultural diversity.

Keep ReadingShow less
Maha-kumbh-pilgrims-reuters

Devotees arrive at the river bank to take a holy dip at Sangam during the Maha Kumbh Mela in Prayagraj, India on January 28, 2025. (Photo: Reuters)

India says 420 million pilgrims have visited Maha Kumbh

INDIA’s government announced on Friday that more than 420 million pilgrims have taken part in ritual bathing at the Maha Kumbh, a Hindu religious festival.

Organisers say the estimate is based on artificial intelligence and surveillance cameras used to track attendance.

Keep ReadingShow less
Bird-flu-Getty

There have been 27 confirmed cases of bird flu in England and one in Scotland during the current outbreak. (Representational image: Getty Images)

England bans 'bird gatherings' to contain avian flu spread

THE GOVERNMENT has announced a ban on "bird gatherings" in England as part of efforts to contain the spread of avian influenza.

The ban, which comes into effect from midday on Monday, will apply to fairs, markets, and shows involving various bird species.

Keep ReadingShow less
Matt-Jukes-Getty

Matt Jukes, the UK’s head of counterterrorism, has called for a social media ban for children under 16. (Photo: Getty Images)

Nine-year-old among youngest referred for far-right deradicalisation

A UK charity working to counter far-right radicalisation has seen children as young as nine referred for support.

Exit Hate UK, which helps individuals leave extremist movements, said its youngest-ever referral was nine years old, with the average age of those seeking help being about 15, according to The Times.

Keep ReadingShow less